Company Aimmune Therapeutics, Inc.
Equities
AIMT
US00900T1079
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Compliance Officer | 57 | 20-09-30 | |
Jim Pepin
LAW | General Counsel | - | - |
Samina Bari
PRN | Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 65,450,142 | 50,930,993 ( 77.82 %) | 0 | 77.82 % |
Company contact information
Aimmune Therapeutics, Inc.
1007 US Highway 202/206 Building JR2
08807, Bridgewater
+650 614 5220
http://www.aimmune.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |